Confirmation of Di(2-ethylhexyl) phthalate-induced micronuclei by repeated dose liver micronucleus assay: focus on evaluation of liver micronucleus assay in young rats.
Carcinogen
In vivo
Liver
Micronucleus
Phthalate
Rats
Journal
Genes and environment : the official journal of the Japanese Environmental Mutagen Society
ISSN: 1880-7046
Titre abrégé: Genes Environ
Pays: England
ID NLM: 101285347
Informations de publication
Date de publication:
23 Aug 2024
23 Aug 2024
Historique:
received:
16
03
2024
accepted:
12
08
2024
medline:
24
8
2024
pubmed:
24
8
2024
entrez:
23
8
2024
Statut:
epublish
Résumé
Di(2-ethylhexyl) phthalate (DEHP) is a plasticizer commonly used in a wide variety of products, including medical devices. It is rapidly metabolized in the liver into various metabolites upon absorption through oral ingestion, dermal absorption, and inhalation. DEHP is classified as a non-genotoxic hepatocarcinogen in rodents, as its chronic exposure has been associated with the development of liver cancer in these animals, but most genotoxicity studies have been negative. Epidemiologic studies in humans suggest that long-term high intakes of DEHP may be a risk factor for liver dysfunction. The repeated-dose liver micronucleus (RDLMN) assay is a well-established method for assessing chromosomal changes caused by hepatic genotoxins and/or carcinogens. It is particularly valuable for detecting substances that undergo metabolic activation, especially when the metabolite has a short half-life or does not reach the bone marrow effectively. Therefore, we investigated whether the RDLMN assay could detect DEHP-induced micronucleus formation in the liver following a 14 or 28-day treatment. We report that the RDLMN assay demonstrated an increased frequency of hepatic micronuclei in rats exposed to DEHP for 14 or 28 days. The increases in micronuclei correlated with hepatomegaly, an established response to phthalates in the liver. Conversely, no such increases were observed in the micronucleus assay using bone marrow from these rats. The detection of DEHP-induced micronuclei by the RDLMN assay suggests that this assay could detect the potential genotoxicity and hepatocarcinogenicity of DEHP. It also demonstrated the utility of the RDLMN assay in identifying metabolically activated hepatic carcinogens.
Sections du résumé
BACKGROUND
BACKGROUND
Di(2-ethylhexyl) phthalate (DEHP) is a plasticizer commonly used in a wide variety of products, including medical devices. It is rapidly metabolized in the liver into various metabolites upon absorption through oral ingestion, dermal absorption, and inhalation. DEHP is classified as a non-genotoxic hepatocarcinogen in rodents, as its chronic exposure has been associated with the development of liver cancer in these animals, but most genotoxicity studies have been negative. Epidemiologic studies in humans suggest that long-term high intakes of DEHP may be a risk factor for liver dysfunction. The repeated-dose liver micronucleus (RDLMN) assay is a well-established method for assessing chromosomal changes caused by hepatic genotoxins and/or carcinogens. It is particularly valuable for detecting substances that undergo metabolic activation, especially when the metabolite has a short half-life or does not reach the bone marrow effectively. Therefore, we investigated whether the RDLMN assay could detect DEHP-induced micronucleus formation in the liver following a 14 or 28-day treatment.
RESULTS
RESULTS
We report that the RDLMN assay demonstrated an increased frequency of hepatic micronuclei in rats exposed to DEHP for 14 or 28 days. The increases in micronuclei correlated with hepatomegaly, an established response to phthalates in the liver. Conversely, no such increases were observed in the micronucleus assay using bone marrow from these rats.
CONCLUSION
CONCLUSIONS
The detection of DEHP-induced micronuclei by the RDLMN assay suggests that this assay could detect the potential genotoxicity and hepatocarcinogenicity of DEHP. It also demonstrated the utility of the RDLMN assay in identifying metabolically activated hepatic carcinogens.
Identifiants
pubmed: 39180124
doi: 10.1186/s41021-024-00311-x
pii: 10.1186/s41021-024-00311-x
doi:
Types de publication
Journal Article
Langues
eng
Pagination
17Informations de copyright
© 2024. The Author(s).
Références
National Toxicology Program. Report on Carcinogens, Fifteenth Edition Di(2-ethylhexyl) Phthalate. U.S. Department of Health and Human Services. Available from: https://ntp.niehs.nih.gov/sites/default/files/ntp/roc/content/profiles/diethylhexylphthalate.pdf ; [cited 2024 Jan 22].
Maloney EK, Waxman DJ. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol Appl Pharmacol. 1999;161:209–18.
doi: 10.1006/taap.1999.8809
pubmed: 10581215
Li A, Kang L, Li R, Wu S, Liu K, Wang X. Modeling di (2-ethylhexyl) Phthalate (DEHP) and its metabolism in a body’s organs and tissues through different intake pathways into human body. Int J Environ Res Public Health. 2022;19:5742.
doi: 10.3390/ijerph19095742
pubmed: 35565138
pmcid: 9101911
Martinez-Arguelles DB, Culty M, Zirkin BR, Papadopoulos V. In utero exposure to di-(2-ethylhexyl) phthalate decreases mineralocorticoid receptor expression in the adult testis. Endocrinology. 2009;150:5575–85.
doi: 10.1210/en.2009-0847
pubmed: 19819939
pmcid: 2795714
Chen X, Xu S, Tan T, Lee ST, Cheng SH, Lee FWF, et al. Toxicity and estrogenic endocrine disrupting activity of phthalates and their mixtures. Int J Environ Res Public Health. 2014;11:3156–68.
doi: 10.3390/ijerph110303156
pubmed: 24637910
pmcid: 3987027
Rowdhwal SSS, Chen J. Toxic Effects of Di-2-ethylhexyl Phthalate: An Overview. BioMed Res Int. 2018;2018:1750368.
doi: 10.1155/2018/1750368
pubmed: 29682520
pmcid: 5842715
Erythropel HC, Maric M, Nicell JA, Leask RL, Yargeau V. Leaching of the plasticizer di(2-ethylhexyl)phthalate (DEHP) from plastic containers and the question of human exposure. Appl Microbiol Biotechnol. 2014;98:9967–81.
doi: 10.1007/s00253-014-6183-8
pubmed: 25376446
Wang Y, Zhu H, Kannan K. A review of biomonitoring of phthalate exposures. Toxics. 2019;7:21.
doi: 10.3390/toxics7020021
pubmed: 30959800
pmcid: 6630674
Jia PP, Ma YB, Lu CJ, Mirza Z, Zhang W, Jia YF, et al. The Effects of Disturbance on Hypothalamus-Pituitary-Thyroid (HPT) Axis in Zebrafish Larvae after Exposure to DEHP. PLoS ONE. 2016;11:e0155762.
doi: 10.1371/journal.pone.0155762
pubmed: 27223697
pmcid: 4880181
Rusyn I, Peters JM, Cunningham ML. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol. 2006;36:459–79.
doi: 10.1080/10408440600779065
pubmed: 16954067
pmcid: 2614359
Noriega NC, Howdeshell KL, Furr J, Lambright CR, Wilson VS, Gray LE. Pubertal administration of DEHP delays puberty, suppresses testosterone production, and inhibits reproductive tract development in male Sprague-Dawley and Long-Evans rats. Toxicol Sci Off J Soc Toxicol. 2009;111:163–78.
doi: 10.1093/toxsci/kfp129
Hannon PR, Peretz J, Flaws JA. Daily exposure to Di(2-ethylhexyl) phthalate alters estrous cyclicity and accelerates primordial follicle recruitment potentially via dysregulation of the phosphatidylinositol 3-kinase signaling pathway in adult mice. Biol Reprod. 2014;90:136.
doi: 10.1095/biolreprod.114.119032
pubmed: 24804967
pmcid: 4435463
Lin H, Yuan K, Li L, Liu S, Li S, Hu G, et al. In utero exposure to diethylhexyl phthalate affects rat brain development: a behavioral and genomic approach. Int J Environ Res Public Health. 2015;12:13696–710.
doi: 10.3390/ijerph121113696
pubmed: 26516888
pmcid: 4661608
Rusyn I, Corton JC. Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate. Mutat Res. 2012;750:141–58.
doi: 10.1016/j.mrrev.2011.12.004
pubmed: 22198209
Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, et al. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol. 2003;33:655–780.
doi: 10.1080/713608372
pubmed: 14727734
Ito Y, Yamanoshita O, Asaeda N, Tagawa Y, Lee C-H, Aoyama T, et al. Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway. J Occup Health. 2007;49:172–82.
doi: 10.1539/joh.49.172
pubmed: 17575397
Yang Q, Ito S, Gonzalez FJ. Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis. Carcinogenesis. 2007;28:1171–7.
doi: 10.1093/carcin/bgm046
pubmed: 17331954
Ghosh J, Das J, Manna P, Sil PC. Hepatotoxicity of di-(2-ethylhexyl)phthalate is attributed to calcium aggravation, ROS-mediated mitochondrial depolarization, and ERK/NF-κB pathway activation. Free Radic Biol Med. 2010;49:1779–91.
doi: 10.1016/j.freeradbiomed.2010.09.011
pubmed: 20854900
National Toxicology Program. https://cebs.niehs.nih.gov/cebs/test_article/117-81-7 . Accessed 2024 May 18.
Madle S, Dean SW, Andrae U, Brambilla G, Burlinson B, Doolittle DJ, et al. Recommendations for the performance of UDS tests in vitro and in vivo. Mutat Res Environ Mutagen Relat Subj. 1994;312:263–85.
Lambert IB, Singer TM, Boucher SA, Douglas GR. Detailed review of transgenic rodent mutation assays. Mutat Res Rev Mutat Res. 2005;590:1–280.
doi: 10.1016/j.mrrev.2005.04.002
Corton JC, Peters JM, Klaunig JE. The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. Arch Toxicol. 2018;92:83–119.
doi: 10.1007/s00204-017-2094-7
pubmed: 29197930
Kirkland D, Kasper P, Martus HJ, Müller L, van Benthem J, Madia F, et al. Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests. Mutat Res Genet Toxicol Environ Mutagen. 2016;795:7–30.
doi: 10.1016/j.mrgentox.2015.10.006
pubmed: 26774663
O’Brien ML, Spear BT, Glauert HP. Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit Rev Toxicol. 2005;35:61–88.
doi: 10.1080/10408440590905957
pubmed: 15742903
Wang W, Craig ZR, Basavarajappa MS, Hafner KS, Flaws JA. Mono-(2-Ethylhexyl) phthalate induces oxidative stress and inhibits growth of mouse ovarian antral follicles. Biol Reprod. 2012;87:152.
pubmed: 23077170
pmcid: 4435432
Nakajima T, Hopf NB, Schulte PA. IRCA Monographs Di(2-ethylhexyl) phthalate (DEHP). IARC. 2000;77:41–148.
ECHA. Support Document for Identification of DEHP. European Chemicals Agency; 2014. https://echa.europa.eu/documents/10162/fa429d23-21e7-4764-b223-6c8c98f8a01c .
Cambien G, Dupuis A, Guihenneuc J, Bauwens M, Belmouaz M, Ayraud-Thevenot S. Endocrine disruptors in dialysis therapies: a literature review. Environ Int. 2023;178: 108100.
doi: 10.1016/j.envint.2023.108100
pubmed: 37481953
Hamada S, Ohyama W, Takashima R, Shimada K, Matsumoto K, Kawakami S, et al. Evaluation of the repeated-dose liver and gastrointestinal tract micronucleus assays with 22 chemicals using young adult rats: summary of the collaborative study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/The Japanese Environmental Mutagen Society (JEMS) - Mammalian Mutagenicity Study Group (MMS). Mutat Res Genet Toxicol Environ Mutagen. 2015;780–781:2–17.
doi: 10.1016/j.mrgentox.2015.01.001
pubmed: 25892619
Narumi K, Ashizawa K, Takashima R, Takasawa H, Katayama S, Tsuzuki Y, et al. Development of a repeated-dose liver micronucleus assay using adult rats: an investigation of diethylnitrosamine and 2,4-diaminotoluene. Mutat Res. 2012;747:234–9.
doi: 10.1016/j.mrgentox.2012.05.012
pubmed: 22677510
Kawabata M, Takasawa H, Minowa S, Saitou H, Nakagawa M, Nakajima M, et al. New method of specimen preparation as cell suspension for a micronucleus test. Genes Environ. 2007;29:100–6.
doi: 10.3123/jemsge.29.100
Satomoto K, Aoki M, Wakita A, Yamagata H, Mitsumoto T, Okamoto T, et al. Hepatocyte proliferation activity in untreated rats, measured by immunohistochemical detection of Ki-67: The effect of age on the repeated-dose liver micronucleus assay. Mutat Res Genet Toxicol Environ Mutagen. 2023;890: 503658.
doi: 10.1016/j.mrgentox.2023.503658
pubmed: 37567645
Phillips DH, Arlt VM. Genotoxicity: damage to DNA and its consequences. EXS. 2009;99:87–110.
pubmed: 19157059
Xu B, Wang W, Guo H, Sun Z, Wei Z, Zhang X, et al. Oxidative stress preferentially induces a subtype of micronuclei and mediates the genomic instability caused by p53 dysfunction. Mutat Res. 2014;770:1–8.
doi: 10.1016/j.mrfmmm.2014.08.004
pubmed: 25302047
pmcid: 4186711
Kasai H, Okada Y, Nishimura S, Rao MS, Reddy JK. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res. 1989;49:2603–5.
pubmed: 2713844
Krupina K, Goginashvili A, Cleveland DW. Causes and consequences of micronuclei. Curr Opin Cell Biol. 2021;70:91–9.
doi: 10.1016/j.ceb.2021.01.004
pubmed: 33610905
pmcid: 8119331
Ye H, Ha M, Yang M, Yue P, Xie Z, Liu C. Di2-ethylhexyl phthalate disrupts thyroid hormone homeostasis through activating the Ras/Akt/TRHr pathway and inducing hepatic enzymes. Sci Rep. 2017;7:40153.
doi: 10.1038/srep40153
pubmed: 28065941
pmcid: 5220292
Crobeddu B, Ferraris E, Kolasa E, Plante I. Di(2-ethylhexyl) phthalate (DEHP) increases proliferation of epithelial breast cancer cells through progesterone receptor dysregulation. Environ Res. 2019;173:165–73.
doi: 10.1016/j.envres.2019.03.037
pubmed: 30909102
Kim JH. Analysis of the in vitro effects of di-(2-ethylhexyl) phthalate exposure on human uterine leiomyoma cells. Exp Ther Med. 2018;15:4972–8.
pubmed: 29805520
pmcid: 5958751